Interventions for Shiga toxin-producing Escherichia coli gastroenteritis and risk of hemolytic uremic syndrome: A population-based matched case control study

Shota Myojin(Nihon University), Isao Miyairi(National Center For Child Health and Development), Tomimasa Sunagawa(National Institute of Infectious Diseases), Kyongsun Pak(National Center For Child Health and Development), Ichiro Morioka(Nihon University), Mitsuru Kubota(National Center For Child Health and Development), Kenji Ishikura(Kitasato University), Tohru Kobayashi(National Center For Child Health and Development), Takashi Igarashi(National Center For Child Health and Development), Takuri Takahashi(National Institute of Infectious Diseases), Masaya Kubota(Tokyo Metropolitan Children's Medical Center), Mayumi Sako(National Center For Child Health and Development), Norihiko Tsuboi(National Center For Child Health and Development)
PLoS ONE
February 4, 2022
10.1371/journal.pone.0263349
Cited by 12

Related Papers

Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial
|The Lancet|2014|450
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|278
Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease
|Clinical and Experimental Nephrology|2013|267
Epidemiology of pediatric chronic kidney disease/kidney failure: learning from registries and cohort studies
|Pediatric Nephrology|2021|149
A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment
|Kidney International|2014|135